Challenges in Gene Therapy: A Pioneer's Shift

This chapter analyzes the departure of gene therapy pioneer Jim Wilson from the University of Pennsylvania and its implications for academic research in the biotech sector. It highlights the significant market downturn, reduced funding, and the establishment of two new companies aimed at addressing emerging challenges in gene therapy development. The discussion underscores the evolving landscape of biotech, prompting institutions to rethink their roles and strategies for innovation.